Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts

Journal of Surgical Research

Volumn 80, Issue 2, 1998, Pages 164-170

  Annex, Brian H ^a   Davies, Mark G ^a   Fulton, Gregory J ^a   Huynh, Tam T T ^a   Channon, Keith M ^a   Ezekowitz, Michael D ^b   Hagen, Per Otto ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intimal hyperplasia; Tissue Factor; Vein graft

Indexed keywords

ANTIBODY; CD18 ANTIGEN; POLOXAMER; THROMBOPLASTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; VEIN GRAFT;

EID: 0032418249     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5438     Document Type: Article

References (32)

1. Cox J. L., Chaisson D. A., Gotlieb A. I. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog. Cardiovasc. Dis. 34:1991;455.
2. Davies M. G., Hagen P-O. Pathophysiology of vein graft failure. Eur. J. Vasc. Endovasc. Surg. 9:1995;7
3. Rapp J. H., Pan X-M., Ghermay A., Gazetas P., Brady S. E., Reilly L. M. A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model. J. Vasc. Surg. 25:1997;726.
4. Carson S. D., Bronza J. P. The role of tissue factor in the production of thrombin. Blood Coagul. Fibrinolysis. 4:1993;281.
5. Channon K. M., Fulton G. J., Davies M. G. Intimal Tissue Factor Protein expression precedes intimal hyperplasia in experimental venous bypass grafts. Arterioscler. Thromb. Vasc. Biol. 17:1997;1313.
6. Schwartz L. B., Pence J. C., Kerns B. J., Iglehart J. D., McCann R. L., Hagen P-O. Kinetics of vein graft cell division and function. Surg. Forum. 47:1991;362.
7. Davies M. G., Barber L., Dalen H., Svendsen E. Hagen P-O. Pharmacologic control of the structural and functional consequences of vein graft intimal hyperplasia by a 21-aminosteroid (U74389G). Eur. J. Vasc. Surg. 8:1994;156.
8. Fulton G. J., Davies M. G., Koch W. J., Dalen H., Svendsen E. Hagen P-O. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts. J. Vasc. Surg. 25:1997;453.
9. Fulton G. J., Davies M. G., Gray J. L., Barber L., Svendsen E., Hagen P-O. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts. Eur. J. Vasc. Endovasc. Surg. 15:1998;279.
10. Pawashe A. B., Golino P., Ambrosio G. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ. Res. 74:1994;56.
11. Ragni M., Cirillo P., Pascucci I. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulaion. 93:1996;1913.
12. Galea-Lauri J., Blackford J., Wilkinson J. M. The expression of CD11/CD18 molecules on rabbit leukocytes: Identification of monoclonal antibodies to CD18 and their effect on cellular adhesion processes. Mol. Immunol. 30:1993;529.
13. Smith C. W., Rothlein R., Hughes B. J. Recognition of an endothelial determinant for CD18-dependent human neutrophil adherence and transendothelial migration. J. Clin. Invest. 82:1988;1746.
14. Zwolak R. M., Kirkman T. R., Clowes A. W. Atherosclerosis in rabbit vein grafts. Arteriosclerosis. 9:1989;374.
15. Hansson G. K., Seifert P. S., Olsson G., Bondjers G. Immunohistochemical detection of macrophages and T-lymphocytes in atherosclerotic lesion of cholesterol-fed rabbits. Arterioscler. Thromb. 11:1991;745.
16. Liaw L., Lombardi D. M., Almeida M. M., Schwartz S. M., deBlois D., Giachelli C. M. Neutralizing antibodies directed against osteopontin inhibits rat carotid neointimal thickening after endothelial denudation. Arterioscler. Thromb. Vasc. Biol. 17:1997;188.
17. Marmur J. D., Rossikhina M., Guha A. Tissue Factor is rapidly induced in arterial smooth muscle after balloon injury. J. Clin. Invest. 91:1993;2253.
18. Speidel C. M., Eisenberg P. R., Ruf W., Edgington T. S., Abendschein D. R. Tissue Factor mediates prolonged procoagulant activity on the luminal surface of balloon injured aortas in rabbits. Circulation. 92:1995;3323.
19. McNamara M. C., Sarembock I. J., Gimple L. W., Fenton J. W., Coughlin S. R., Owens G. K. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91:1993;94.
20. Fager G. Thrombin and proliferation of vascular smooth muscle cells. Circ. Res. 77:1995;645.
21. Drake W. T., Lopes N. N., Fenton J. W., Issekutz A. C. Thrombin enhancement of interleukin-1 and tumor necrosis factor-alpha induced polymorphonuclear leukocyte migration. Lab. Invest. 67:1992;617.
22. Macconi D., Foppolo M., Paris S. PAF mediates neutrophil adhesion to thrombin or TNF-stimulated endothelial cells under shear stress. Am. J. Physiol. 269:1995;C42.
23. Sarembock I. J., Gertz S. D., Gimple L. W., Owen R. M., Powers E. R., Roberts W. C. Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation. 84:1991;232.
24. Brown D. M., Kania N. M., Choi E. T. Local irrigation with tissue factor pathway inhibitor inhibits intimal hyperplasia induced by arterial interventions. Arch. Surg. 131:1996;1086.
25. Rade J. J., Schulick A. H., Virani R., Dichek D. A. Local adenoviral mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nature Med. 2:1996;293.
26. Hoch J. R., Stark V. K. Apoptosis in vein graft intimal hyperplasia. Surg. Forum. XLVII:1996;357.
27. Davies M. G., Klyachkin M. L., Dalen H., Massey M., Svendsen E. Hagen P-O. The integrity of experimental vein graft endothelium:implications on the etiology of early graft failure. Eur. J. Vasc. Surg. 7:1993;156.
28. Davies M. G., Hagen P-O. Pathobiology of intimal hyperplasia. Br. J. Surg. 81:1994;1254.
29. Zhang Y., Deng Y., Luther T. Tissue Factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J. Clin. Invest. 94:1994;1320.
30. Bromberg M. E., Konigberg W. H., Madison J. F., Pawashe A., Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc. Natl. Acad. Sci. USA. 92:1995;8205.
31. Luo Z., Asahara T., Tsurui Y., Isner J. M., Symes J. F. Reduction of vein graft intimal hyperplasia and preservation of endothelium dependent relaxation by topical VEGF. J. Vasc. Surg. 27:1998;167.
32. Huynh T. T. T., Davies M. G., Annex B. H., Peters K. Hagen P-O. Alterations in vascular endothelial cell growth factor expression in experimental vein bypass grafts. FASEB J. 11:1997;A338.